Specifically, the risks and uncertainties that may affect the development of pixantrone, risks with preclinical and clinical developments in the biopharmaceutical industry in general and with pixantrone in particular, including, without limitation, the results of complete safety and progression-free survival time for pixantrone to is still mounted to the potential failure of pixantrone to prove safe and effective for the treatment of relapsed aggressive NHL , such as the FDA, the determination of the FDA that the PIX301 trial is not sufficient to, an NDA, the company’s ability continue to support capital cessary to its operations, competitive factors, technological developments, costs of developing, producing and selling pixantrone, and the risk factors listed or described from time to time the Company’s filings the Company’s filings with the Securities and Exchange Commission including, without limitation that fund.

CTI intends further evaluate additional details of the study and complete safety and progression-free survival compared with treatment information tasks that currently supply mounted for analysis.This year, more than 500,000 Americans will find a first heart attack, almost all of whom that come from the SHAPE total eligible population. – ‘There is clear that new policy strategies are required to combat the growing epidemic of atherosclerotic cardiovascular disease,’said Dr. Valentin Fuster, former president of American Heart Association and director of of the Cardiovascular Institute at Mount Sinai Medical centers in New York, wrote a leading article to comment in special edition the American College of Cardiology is dedicated to the SHAPE directive. percent 2’By the traditional risk evaluation to SHAPE guideline was potential to turn in the field of preventive cardiology. ‘.